YIH
AGIO icon

Y-Intercept (HK)’s Agios Pharmaceuticals AGIO Stock Holding History

Y-Intercept (HK)’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,866
Closed -$469K – 1662
2026
Q1 		$469K Sell
13,866
-65,965
-83% -$1.87M 0.01% 1272
2025
Q4 		$2.17M Buy
79,831
+71,899
+906% +$2.52M 0.05% 590
2025
Q3 		$318K Buy
+7,932
New +$298K 0.01% 1362
2025
Q1 		– Sell
-45,817
Closed -$1.51M – 1154
2024
Q4 		$1.51M Buy
+45,817
New +$2.15M 0.1% 283
2024
Q3 		– Sell
-25,945
Closed -$1.12M – 1257
2024
Q2 		$1.12M Buy
+25,945
New +$936K 0.06% 446
2022
Q4 		– Sell
-11,246
Closed -$318K – 962
2022
Q3 		$318K Buy
+11,246
New +$302K 0.03% 686

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Y-Intercept (HK)'s AGIO Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Agios Pharmaceuticals (AGIO) in Q2 2026, closing a stake of 13,866 shares — an estimated $469K sold.

Y-Intercept (HK) first reported a position in AGIO in Q3 2022 and held it in 6 quarters. The position peaked at $2.17M in Q4 2025. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Y-Intercept (HK) reported no remaining Agios Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Y-Intercept (HK) sold 13,866 Agios Pharmaceuticals shares in Q2 2026, an estimated $469K.
  • Y-Intercept (HK) first reported a position in Agios Pharmaceuticals in Q3 2022 and held it in 6 quarters.
  • Y-Intercept (HK)'s Agios Pharmaceuticals position peaked at $2.17M in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.